Nevro Corp (NYSE:NVRO), a medical device company ... This performance led to a positive market reaction, with the stock price increasing by 20% following the earnings announcement.

Nevro NVRO is well-poised for growth in the coming quarters, courtesy of its business expansion plans and restructuring activities. The optimism, led by a decent preliminary full-year 2024 ...

Nevro Corp. (NYSE:NVRO – Get Free Report ... Two analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the company.

This compares to the stock's 43.8% gain over the past four weeks. The recent surge in Nevro shares can be attributed to the announcement of Globus Medical acquiring Nevro in an-all cash ...

Nevro Corp is set to release its Q4 2024 earnings on Mar 4, 2025.The consensus estimate for Q4 2024 revenue is $102.54 million, and the earnings are expected to come in at -$0.79 per share. The ...

March 4, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical ... changes in fair market value of warrants, stock-based compensation, impairment of goodwill and depreciation and ...

Nevro Corp. NVRO reported a loss per share of 64 cents in the fourth quarter of 2024, wider than the year-ago quarter’s loss of 15 cents. The Zacks Consensus Estimate is pegged at a loss per ...

Globus Medical GMED has entered into a definitive agreement to acquire Nevro Corp. NVRO in an all-cash transaction valued at approximately $ ... regulatory approval and other customary closing ...

On February 7, 2025, Nevro Corp was acquired by Globus Medical (NYSE ... This performance led to a positive market reaction, with the stock price increasing by 20% following the earnings announcement.